Mauro Angiolini (43, PhD in Medicinal Chemistry) has 13 Years of experience in the field of Medicinal Chemistry drug discovery in Pharmaceutical Companies (Pharmacia, Pfizer) or Italian Biotech companies (Nerviano Medical Sciences). As Senior Medicinal Chemist he has been involved in many projects related to Oncology with different roles and responsibilities. In the last ten years he focused his research on Kinase Inhibitors drug discovery.

Fabio Zuccotto (45, PhD in Computational Chemistry) has 13 years’ experience in Drug Discovery working both in Academic and Industrial settings. He spent most of his career in the UK. He returned to Italy working for Nerviano Medical Sciences where he was involved in the development of innovative molecular designs of Kinase inhibitors. He was also Team Leader of a multidisciplinary group of scientists focused on Fragment Based Drug Discovery.